| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Surgery Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892
The observation that allogeneic melanoma cells matched for particular HLA class I alleles stimulate T-cells isolated from patients suggests that widely shared antigens exist on these tumors. A transient expression system was developed for screening a melanoma complementary DNA library using the highly transfectable human kidney cell line 293. Using this system, large numbers of complementary DNA clones can be rapidly screened for the expression of antigens which stimulate T-cells. Tumor-infiltrating lymphocytes from patient 888, which recognized melanoma in the context of HLA-A24, were used to screen a complementary DNA library made from the autologous melanoma. Our results demonstrate that these tumor-infiltrating lymphocytes recognize tyrosinase, a gene previously shown to be recognized by T-cells only in the context of HLA-A2. These data demonstrate that a single antigen can be recognized in the context of two different class I HLA alleles. In addition, this study suggests that recognition of tyrosinase by antigen-specific T-cells may be involved in tumor rejection.
1 To whom requests for reprints should be addressed, at Surgery Branch, National Cancer Institute, NIH, Bldg. 10, Room 2B46, 9000 Rockville Pike, Bethesda, MD 20892.
Received 3/25/94. Accepted 5/ 4/94.
This article has been cited by other articles:
|
|
 |
|
  P. F. Robbins, Y. F. Li, M. El-Gamil, Y. Zhao, J. A. Wargo, Z. Zheng, H. Xu, R. A. Morgan, S. A. Feldman, L. A. Johnson, et al. Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions J. Immunol., May 1, 2008; 180(9): 6116 - 6131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Fonsatti, H. J.M. Nicolay, L. Sigalotti, L. Calabro, L. Pezzani, F. Colizzi, M. Altomonte, M. Guidoboni, F. M. Marincola, and M. Maio Functional Up-regulation of Human Leukocyte Antigen Class I Antigens Expression by 5-aza-2'-deoxycytidine in Cutaneous Melanoma: Immunotherapeutic Implications Clin. Cancer Res., June 1, 2007; 13(11): 3333 - 3338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-A. Perales, A. Diab, A. D. Cohen, D. W. Huggins, J. A. Guevara-Patino, V. M. Hubbard, M. E. Engelhorn, A. A. Kochman, J. M. Eng, F. Mortazavi, et al. DNA Immunization against Tissue-Restricted Antigens Enhances Tumor Immunity after Allogeneic Hemopoietic Stem Cell Transplantation J. Immunol., September 15, 2006; 177(6): 4159 - 4167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sensi and A. Anichini Unique Tumor Antigens: Evidence for Immune Control of Genome Integrity and Immunogenic Targets for T Cell-Mediated Patient-Specific Immunotherapy Clin. Cancer Res., September 1, 2006; 12(17): 5023 - 5032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Lindsey, L. Gritz, R. Sherry, A. Abati, P. A. Fetsch, L. C. Goldfeder, M. I. Gonzales, K. A. Zinnack, L. Rogers-Freezer, L. Haworth, et al. Evaluation of Prime/Boost Regimens Using Recombinant Poxvirus/Tyrosinase Vaccines for the Treatment of Patients with Metastatic Melanoma Clin. Cancer Res., April 15, 2006; 12(8): 2526 - 2537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Craft, K. W. Bruhn, B. D. Nguyen, R. Prins, J. W. Lin, L. M. Liau, and J. F. Miller The TLR7 Agonist Imiquimod Enhances the Anti-Melanoma Effects of a Recombinant Listeria monocytogenes Vaccine J. Immunol., August 1, 2005; 175(3): 1983 - 1990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. van Dinten, N. Pul, A. F. van Nieuwpoort, C. J. Out, M. J. Jager, and P. J. van den Elsen Uveal and Cutaneous Melanoma: Shared Expression Characteristics of Melanoma-Associated Antigens Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 24 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Wong, R. Lau, J. Chang, T. Kuus-Reichel, V. Brichard, C. Bruck, and J. Weber Immune Responses to a Class II Helper Peptide Epitope in Patients with Stage III/IV Resected Melanoma Clin. Cancer Res., August 1, 2004; 10(15): 5004 - 5013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ruiz, H. Kobayashi, J. J. Lasarte, J. Prieto, F. Borras-Cuesta, E. Celis, and P. Sarobe Identification and Characterization of a T-Helper Peptide from Carcinoembryonic Antigen Clin. Cancer Res., April 15, 2004; 10(8): 2860 - 2867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ishikawa, T. Fujita, Y. Suzuki, S. Okabe, Y. Yuasa, T. Iwai, and Y. Kawakami Tumor-specific Immunological Recognition of Frameshift-mutated Peptides in Colon Cancer with Microsatellite Instability Cancer Res., September 1, 2003; 63(17): 5564 - 5572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. F. Robbins, M. El-Gamil, Y. F. Li, G. Zeng, M. Dudley, and S. A. Rosenberg Multiple HLA Class II-Restricted Melanocyte Differentiation Antigens Are Recognized by Tumor-Infiltrating Lymphocytes from a Patient with Melanoma J. Immunol., November 15, 2002; 169(10): 6036 - 6047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Mitchell, D. Darrah, D. Yeung, S. Halpern, A. Wallace, J. Voland, V. Jones, and J. Kan-Mitchell Phase I Trial of Adoptive Immunotherapy With Cytolytic T Lymphocytes Immunized Against a Tyrosinase Epitope J. Clin. Oncol., February 15, 2002; 20(4): 1075 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kiniwa, T. Fujita, M. Akada, K. Ito, T. Shofuda, Y. Suzuki, A. Yamamoto, T. Saida, and Y. Kawakami Tumor Antigens Isolated from a Patient with Vitiligo and T-Cell-infiltrated Melanoma Cancer Res., November 1, 2001; 61(21): 7900 - 7907. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Jager, E Jager, and A Knuth Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer J. Clin. Pathol., September 1, 2001; 54(9): 669 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Frost, L. H. Butterfield, V. B. Dissette, J. S. Economou, and B. Bonavida Immunosensitization of Melanoma Tumor Cells to Non-MHC Fas-Mediated Killing by MART-1-Specific CTL Cultures J. Immunol., March 1, 2001; 166(5): 3564 - 3573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kawakami, X. Wang, T. Shofuda, H. Sumimoto, J. P. Tupesis, E. Fitzgerald, and S. A. Rosenberg Isolation of a New Melanoma Antigen, MART-2, Containing a Mutated Epitope Recognized by Autologous Tumor-Infiltrating T Lymphocytes J. Immunol., February 15, 2001; 166(4): 2871 - 2877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Meyer zum Buschenfelde, N. Nicklisch, S. Rose-John, C. Peschel, and H. Bernhard Generation of Tumor-Reactive CTL Against the Tumor-Associated Antigen HER2 Using Retrovirally Transduced Dendritic Cells Derived from CD34+ Hemopoietic Progenitor Cells J. Immunol., October 1, 2000; 165(7): 4133 - 4140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Oelke, U. Moehrle, J.-L. Chen, D. Behringer, V. Cerundolo, A. Lindemann, and A. Mackensen Generation and Purification of CD8+ Melan-A-specific Cytotoxic T Lymphocytes for Adoptive Transfer in Tumor Immunotherapy Clin. Cancer Res., May 1, 2000; 6(5): 1997 - 2005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Nishimura, D. Avichezer, M. C. Custer, C. S. Lee, C. Chen, M. R. Parkhurst, R. A. Diamond, P. F. Robbins, D. J. Schwartzentruber, and S. A. Rosenberg MHC Class I-restricted Recognition of a Melanoma Antigen by a Human CD4+ Tumor Infiltrating Lymphocyte Cancer Res., December 1, 1999; 59(24): 6230 - 6238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kawakami, P. F. Robbins, X. Wang, J. P. Tupesis, M. R. Parkhurst, X. Kang, K. Sakaguchi, E. Appella, and S. A. Rosenberg Identification of New Melanoma Epitopes on Melanosomal Proteins Recognized by Tumor Infiltrating T Lymphocytes Restricted by HLA-A1, -A2, and -A3 Alleles J. Immunol., December 15, 1998; 161(12): 6985 - 6992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-F. Wang, S. L. Johnston, G. Zeng, S. L. Topalian, D. J. Schwartzentruber, and S. A. Rosenberg A Breast and Melanoma-Shared Tumor Antigen: T Cell Responses to Antigenic Peptides Translated from Different Open Reading Frames J. Immunol., October 1, 1998; 161(7): 3596 - 3606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-T. Chen, A. O. Gure, S. Tsang, E. Stockert, E. Jager, A. Knuth, and L. J. Old Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library PNAS, June 9, 1998; 95(12): 6919 - 6923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Stockert, E. Jager, Y.-T. Chen, M. J. Scanlan, I. Gout, J. Karbach, M. Arand, A. Knuth, and L. J. Old A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens J. Exp. Med., April 20, 1998; 187(8): 1349 - 1354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-F. Wang, S. L. Johnston, S. Southwood, A. Sette, and S. A. Rosenberg Recognition of an Antigenic Peptide Derived from Tyrosinase-Related Protein-2 by CTL in the Context of HLA-A31 and -A33 J. Immunol., January 15, 1998; 160(2): 890 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Specht, G. Wang, M. T. Do, J. S. Lam, R. E. Royal, M. E. Reeves, S. A. Rosenberg, and P. Hwu Dendritic Cells Retrovirally Transduced with a Model Antigen Gene Are Therapeutically Effective against Established Pulmonary Metastases J. Exp. Med., October 20, 1997; 186(8): 1213 - 1221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Osanto Vaccine Trials for the Clinician: Prospects for Tumor Antigens Oncologist, October 1, 1997; 2(5): 284 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Le Fur, S. R. Kelsall, W. K. Silvers, and B. Mintz Selective increase in specific alternative splice variants of tyrosinase in murine melanomas: A projected basis for immunotherapy PNAS, May 13, 1997; 94(10): 5332 - 5337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Schmidt, M. Buschle, W. Zauner, H. Kirlappos, K. Mechtler, B. Trska, and M. L. Birnstiel Cell-free tumor antigen peptide-based cancer vaccines PNAS, April 1, 1997; 94(7): 3262 - 3267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-T. Chen, M. J. Scanlan, U. Sahin, O. Tureci, A. O. Gure, S. Tsang, B. Williamson, E. Stockert, M. Pfreundschuh, and L. J. Old A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening PNAS, March 4, 1997; 94(5): 1914 - 1918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Bloom, D. Perry-Lalley, P. F. Robbins, Y. Li, M. El-Gamil, S. A. Rosenberg, and J. C. Yang Identification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 Melanoma J. Exp. Med., February 3, 1997; 185(3): 453 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Naftzger, Y. Takechi, H. Kohda, I. Hara, S. Vijayasaradhi, and A. N. Houghton Immune response to a differentiation antigen induced by altered antigen: A study of tumor rejection and autoimmunity PNAS, December 10, 1996; 93(25): 14809 - 14814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-F. Wang, E. Appella, Y. Kawakami, X. Kang, and S. A. Rosenberg Identification of TRP-2 as a Human Tumor Antigen Recognized by Cytotoxic T Lymphocytes J. Exp. Med., December 1, 1996; 184(6): 2207 - 2216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Todo, R. L. Martuza, S. D. Rabkin, and P. A. Johnson Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing PNAS, May 22, 2001; 98(11): 6396 - 6401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Jager, S. Gnjatic, Y. Nagata, E. Stockert, D. Jager, J. Karbach, A. Neumann, J. Rieckenberg, Y.-T. Chen, G. Ritter, et al. Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers PNAS, October 24, 2000; 97(22): 12198 - 12203. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
